Crossmark

Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis

Crossref DOI link: https://doi.org/10.1016/j.abd.2026.501443

Published Print: 2026-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Demir, Yusuf https://orcid.org/0000-0003-3307-5917
Ogun, Hande https://orcid.org/0000-0002-6766-865X
Sulu, Bercemhan https://orcid.org/0000-0003-0895-8865
Oba, Muazzez Cigdem https://orcid.org/0000-0002-9207-0748
Seyahi, Emire https://orcid.org/0000-0003-4965-2918
License Information

Text and Data Mining valid from 2026-09-01

Text and Data Mining valid from 2026-09-01

Version of Record valid from 2026-07-21
More Information

This article is maintained by: Elsevier

Article Title: Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis

Journal Title: Anais Brasileiros de Dermatologia

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2026.501443

Content Type: article

Copyright: © 2026 Published by Elsevier España, S.L.U. on behalf of Sociedade Brasileira de Dermatologia.